Young MSers Keeping Dreams Alive
This will be my final column for this year because of the Christmas and New Year holidays. Rather…
Articles by Ed Tobias
Monkey See, Monkey Do: Helping Hands for People with MS
I was just monkeying around while on vacation a few weeks ago, amazed that the animals jumping between my…
MS News that Caught My Eye Last Week: MS Pain, Your Bioclock, Remyelination
Chronic and Neuropathic Pain in MS Patients Should Be Routinely Evaluated, Study Says The next time a doctor tells…
Using Biotin? It Could Impact Your Lab Results
Be careful if you’re using high-dose biotin (vitamin B7). The biotin in your blood could lead to some false…
Should MS Therapy Prices Reflect How Diligently We Take Our Meds?
Would you be more likely to stick to your MS drug schedule if being diligent lowered the cost of…
MS News That Caught My Eye Last Week: Mavenclad, Steroids, Blood Tests, Laquinimod, MS Diagnosis
Health Canada Approves Merck’s Mavenclad to Treat RRMS The European Union OK’d Mavenclad back in August. Now,…
What I Learned About My MS While on Vacation
You wouldn’t think that a guy who was diagnosed with MS more than 37 years ago would still…
Social Media’s World of MS Misinformation
I’m worried about social media. Specifically, I’m worried about the many MS-related groups in the Facebook world. There…
A Wheelchair that Drives Itself
I never thought I’d find a subject for this MS column in the technology magazine Wired. But,…
She Has MS and She Just Hiked 500 Miles
Well, 460.75 miles (741.5 km), to be exact. When I wrote about April Hester in late September, the…
Flu Shot or No Flu Shot for MS Patients?
It’s that time of year again. The time of year where I keep seeing posts on MS social…
MS News That Caught My Eye Last Week: Cannabis Studies, Oral Therapy Study, and Exercising with Wii
MMJ Hires Lead Investigator for Phase 2 Trials of Medicinal Cannabis to Treat Progressive MS The real…
Airport Tips for Holiday Flyers
Thanksgiving is just a few days away, so I thought it would be a good time to repeat a…
Thanks to Caregivers Who Share Our MS Load
The MS load we carry is heavy. Some of us, unfortunately, must carry it alone. But many of…
MS News That Caught My Eye Last Week: Myelin Repair, MS Blood Test, Comparing DMTs
Myelin-producing Brain Cells Regenerated Using Stem Cells in Early Study We know that when the myelin coating…
Thinking About Stopping Your MS Treatments?
Have you ever thought about stopping whatever MS treatment you’re using? I have. So has John Corboy. Corboy’s…
MS News That Caught My Eye Last Week: Older Patients, Stem Cells, Myelin, B-cells vs. T-cells
#MSParis2017 – Trial to See if Disease-modifying Therapies Not Necessary in Older MS Patients This tops my…
Dealing with Disaster While Dealing with MS
Are you ready for a disaster? Wildfires in the wine country of Northern California exploded so quickly that…
MS Relapses May Be Significantly Under-Reported. Duh.
This comes as no surprise to me and probably not to you. MS patients may not always contact…
MS News That Caught My Eye Last Week: #MSParis, Biotin, Tysabri, Lemtrada, Propionic Acid Reports
There’s been a lot of interest in the treatments (including natural treatments) for progressive MS that were presented…
Patients and Neurologists Team Up to Gather MS Therapy Data
Since the approval of the first disease-modifying drug (DMD) for MS back in the mid-1990s, another dozen or…
When You Read About MS Treatments, Read Past the Headline
There’s been some internet buzz recently about the possibility of an over-the-counter allergy drug that helps to repair…
MS News That Caught My Eye Last Week: Mavenclad, Tecfidera, Ublituximab, Ocrevus
The giant ECTRIMS/ACTRIMS MS conference begins in Paris on Wednesday, Oct. 25, and this column focuses on several of…
Opening People’s Eyes to Our Invisible MS
Those of us who have MS know that our disease can be invisible. We don’t always stumble when we…
MSParis2017 Will Look at New MS Diagnosis Criteria, and a Lot More
The year’s largest gathering of multiple sclerosis “minds” starts on Oct. 25 in Paris. More than 8,000 neurologists,…
MS News That Caught My Eye Last Week: Myelin repair, and Diets High in Fat or Salt
Common Allergy Treatment Restores Protective Neuron Coating in MS, Trial Suggests This is the kind of news…
Specialty Pharmaceuticals Mean Specialty Prices
If you have MS, you’ve probably used a specialty drug. My first was Avonex, which I began to use…
MS News that Caught My Eye Last Week: Lemtrada, Copaxone Generic, ATL1102 Trial, and Brain Stimulation
Lemtrada Prevented Progression of Multiple Sclerosis for Five Years, Study Shows Full disclosure: I’m being treated with…
Therapy That Just Might Beat MS Fatigue
I’ve had a cold for two weeks. So, I’ve been more tired than usual. Too tired, in fact,…
MS News That Caught My Eye Last Week: Scooter-User Falls, Aggressive Treatment, and Brain Inflammation
Falls Common Among Wheelchair, Scooter Users in People with MS, Study Reports It’s happened to me. I’ve…